| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | 0.032 | 0.8 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.007 | 0.8 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.007 | 0.8 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.8 |
| mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | -0.0091 | 0.8 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.0067 | 0.8 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | 0.007 | 0.8 |